Skip to main content

After diagnosis | Planning osteosarcoma treatment

Osteosarcoma: Tests and Treatment After Diagnosis

Understanding the next decision, including what treatment could mean for your arm or leg.

An open cream paper folder holding an ivory bone model and three blank blue cards.

After an osteosarcoma diagnosis, you may hear about chemotherapy and surgery at the same appointment. For high-grade osteosarcoma, both are usually needed. Understanding how they fit together can make the next discussion easier to follow.[1]

On this page

You do not have to absorb every detail at once. The first conversation should explain the treatment goal, the decisions already made and the results still needed. A notebook or someone you trust beside you can help.

Will I lose my arm or leg?

If this is your first question, bring it into the conversation early. An osteosarcoma diagnosis does not automatically mean amputation. For a tumour in an arm or leg, limb-preserving surgery may be possible when the cancer can be removed with an adequate margin of healthy tissue around it. The extent of the tumour and the function expected after reconstruction both matter.[1][3]

Some surgical decisions may still be unsettled. The team should explain what remains uncertain and when the options can be reviewed. There should be room to discuss the fear of losing a limb while those questions are still being answered.

Check the complete diagnosis first

This guide mainly describes the pathway for conventional high-grade osteosarcoma. Some low-grade forms, including parosteal osteosarcoma, can be treated with surgery alone. The exact tumour name and grade therefore matter.[1]

Treatment planning belongs with a specialist multidisciplinary team experienced in osteosarcoma.[2] The plan should identify who coordinates your care and whom to contact between appointments. Copies of reports you already have are useful; the team should help obtain missing reports and images.

Why more scans may be needed

The tests used for staging look beyond the original tumour. European guidance for children and adolescents separates local imaging, assessment of the lungs and a search for disease elsewhere in the skeleton.[3]

Different scans answer different questions[3]
AssessmentPurpose
Local MRIMap the tumour within the affected bone and around nearby structures.
Chest CTLook for spread to the lungs.
Whole-body imagingLook for bone disease elsewhere; the team selects the imaging method.

The staging review should bring the results together, explain any finding that needs clarification and show how it affects the proposed plan.

Checks and conversations before chemotherapy

Baseline tests assess blood counts and organ function. Heart, kidney and hearing checks help establish whether treatment can be given and provide a starting point for monitoring its effects.[2]

For children and adolescents, European guidance recommends discussing the planned treatment, side effects and fertility preservation with the patient and family before chemotherapy begins.[3] The explanation should suit the young person’s age and make clear which decisions need to be made now.

If you are a parent, make space for your child's questions as well as your own. Young people should be included in treatment discussions, with explanations suited to their age and understanding.[6] You could each write down the question you most want answered. The operation, school, friends, the future. The two lists do not have to be the same.

How chemotherapy and surgery fit together

High-grade osteosarcoma can have microscopic disease outside the primary tumour even when staging shows no visible spread. Chemotherapy therefore has a purpose beyond treating the visible tumour.[2]

One usual sequence, with two treatment roles

Conventional high-grade osteosarcoma. A usual sequence, without fixed dates.

  1. FIRST

    Chemotherapy

    Treatment can act beyond the visible tumour.

    Systemic treatment
  2. THEN

    Surgery

    The operation aims to remove the tumour with adequate margins.

    Local treatment
  3. FOLLOWED BY

    Further chemotherapy

    Systemic treatment continues after the operation.

    Systemic treatment

Some low-grade osteosarcomas are treated with surgery alone. The operation and any reconstruction depend on the individual tumour.[1]

The sequence and timing are tailored to the tumour and the patient. This diagram does not predict whether a particular limb can be preserved.[1][2]

Imaging is repeated before surgery to help plan the operation and assess the disease.[3]

The surgical aim is complete tumour removal with adequate margins. The choice of operation also involves the expected function and possible reconstruction.[3]

For your own plan, ask when the next review is due, what the proposed operation would remove and what function and rehabilitation you might expect afterwards. The team should provide a written outline of the agreed stages of treatment.

What the removed tumour tells the team

A pathologist examines the surgical specimen to assess the response to preoperative chemotherapy. Greater tumour destruction is associated with a more favourable outlook. A poorer response does not mean chemotherapy was useless and is not, by itself, a reason to stop postoperative treatment.[1]

A poor response does not automatically mean that adding more drugs will help. EURAMOS-1 tested an extra drug combination after surgery in patients aged 40 or younger with removable high-grade tumours that had responded poorly. It caused more side effects without showing a benefit in delaying serious events such as the cancer returning or getting worse. That result concerns the combination tested; it does not settle every possible treatment change.[4]

More about the evidence

EURAMOS-1 tested adding ifosfamide and etoposide to a standard postoperative combination. Event-free survival measured time to recurrence, progression, another cancer or death.[4]

Ask what the response means for your own plan and whether a clinical trial is relevant.

Support during treatment and after it ends

Chemotherapy can lower infection-fighting white blood cells. Infections during cancer treatment can become serious and need urgent attention.[5]

Contact your cancer team immediately

If you develop fever, chills or other signs of infection during treatment, contact your cancer team immediately for advice.[5] Before treatment starts, the team should explain the daytime and out-of-hours contact arrangements, including where to seek care if they cannot be reached.

Rehabilitation addresses the physical, psychological and social effects of treatment. Follow-up also checks for recurrence and longer-term treatment effects.[2] The follow-up plan should also explain how support with school, work and everyday activities fits into these reviews.

You should leave with a clear next step and a review date. If the plan changes, the team should explain the new information behind that decision and update the written outline with you.

Frequently Asked Questions

Does osteosarcoma mean I will need an amputation?

Not automatically. For osteosarcoma in an arm or leg, limb-preserving surgery may be possible if the tumour can be removed with an adequate margin of healthy tissue around it. Tumour extent, reconstruction and the function expected afterwards all matter. The diagnosis alone cannot settle the operation. [1][3]

Does chemotherapy always come before osteosarcoma surgery?

It usually comes before surgery in the high-grade treatment pathway, with further chemotherapy afterwards. The sequence can differ, and some low-grade osteosarcomas are treated with surgery alone. [1]

Does a poor response mean chemotherapy did not work?

No. Less tumour destruction in the surgical specimen carries prognostic information, but it does not establish that chemotherapy provided no benefit. [1]

Why are heart, kidney and hearing tests needed?

These checks establish organ function before treatment and help the team monitor the effects of chemotherapy. They are part of assessing treatment fitness and toxicity. [2]

Will adding more chemotherapy drugs improve a poor response?

That cannot be assumed. EURAMOS-1 tested one additional drug combination after surgery in selected poor responders. It increased toxicity without demonstrating better event-free survival. The result does not answer every possible treatment-change question. [4]

Your consultation

Discuss the next steps in osteosarcoma care

To discuss your osteosarcoma diagnosis and the proposed treatment plan, you can book a consultation with Dr. Vishnu Baburaj at Aster MIMS Kannur.

Share this guide

Know someone who might find this helpful?

Pass this guide on to a friend or family member.

Prefer a copy to keep?

Save the guide for another time.

Download PDF
Preview or print
Preview PDF

The evidence behind this article

  1. National Cancer Institute. Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment (PDQ), Health Professional Version. Living evidence summary, accessed 20 October 2026. Back to: text 1, text 2, text 3, text 4, text 5, text 6, FAQ 1, FAQ 2, FAQ 3
  2. Lindner LH, Andreou D, Bauer S, et al. Osteosarcomas. Onkopedia guideline. April 2026. Sections 5.1, 6.1, 7 and 8. Back to: text 1, text 2, text 3, text 4, text 5, FAQ 4
  3. van Ewijk R, Herold N, et al. European Standard Clinical Practice Recommendations for Children and Adolescents with Primary and Relapsed Osteosarcoma. SIOPE/ERN PaedCan. Version 1, 26 April 2023. Back to: text 1, text 2, text 3, text 4, text 5, text 6, FAQ 1
  4. Marina NM, Smeland S, Bielack SS, et al. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1). An open-label, international, randomised controlled trial. Lancet Oncology. 2016;17:1396–1408. doi:10.1016/S1470-2045(16)30214-5. Back to: text 1, text 2, FAQ 5
  5. National Cancer Institute. Infection and Neutropenia during Cancer Treatment. Reviewed 23 January 2020. Used for infection recognition and urgent contact advice. Back to: text 1, text 2
  6. National Cancer Institute. Support for Families: Childhood Cancer. Reviewed 6 September 2023; accessed 24 October 2026. Used for including young people in discussions and explaining information at an appropriate level. Back to: text 1

Medically reviewed by Dr. Vishnu Baburaj, MS Ortho (PGI Chandigarh), MRCS (UK) · Last reviewed

This article is for educational purposes and does not replace a medical consultation. For personalised advice, book an appointment at Aster MIMS Kannur.

WhatsApp Us Request an appointment